WallStSmart
CRVS

Corvus Pharmaceuticals Inc

NASDAQ: CRVS · HEALTHCARE · BIOTECHNOLOGY

$15.19
+5.34% today

Updated 2026-04-30

Market cap
$1.35B
P/E ratio
P/S ratio
EPS (TTM)
$-0.53
Dividend yield
52W range
$3 – $27
Volume
1.3M

Corvus Pharmaceuticals Inc (CRVS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-0.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-5.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-6.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-11.5%
2026-03-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.15-18.5%$17.84$15.80-11.5%
2025-11-04$-0.12+7.7%$7.68$7.53-2.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.13$-0.15-18.5%
2025-09-30$-0.13$-0.12+7.7%
2025-06-30$-0.13$-0.10+23.1%
2025-03-31$-0.12$-0.14-14.8%
2024-12-31$-0.12$-0.14-19.1%$88000.00-64.2%
2024-09-30$-0.11$-0.60-445.5%
2024-06-30$-0.11$-0.04+63.6%
2024-03-31$-0.13$-0.12+7.7%
2023-12-31$-0.12$-0.14-16.7%$246000.00
2023-09-30$-0.12$-0.12+0.0%
2023-06-30$-0.14$-0.14+0.0%
2023-03-31$-0.16$-0.17-6.3%

Frequently asked questions

Has Corvus Pharmaceuticals Inc beaten earnings estimates?
Corvus Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -0.6% over the last 4 quarters.
How does CRVS stock react to earnings?
CRVS stock has moved an average of -6.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.